Reduced risk of recurrent pneumothorax for sirolimus therapy after surgical pleural covering of entire lung in lymphangioleiomyomatosis

BACKGROUND: Patients with lymphangioleiomyomatosis (LAM) frequently experience pneumothorax. Although sirolimus is the standard therapy for LAM, its effect on pneumothorax is controversial. Recently, total pleural covering (TPC) and modified TPC (mTPC) were introduced as surgical treatment options f...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakurai, Teiko, Arai, Toru, Hirose, Masaki, Kojima, Kensuke, Sakamoto, Tetsuki, Matsuda, Yoshinobu, Sugimoto, Chikatoshi, Yoon, Hyung-Eun, Inoue, Yoshikazu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567719/
https://www.ncbi.nlm.nih.gov/pubmed/34732225
http://dx.doi.org/10.1186/s13023-021-02081-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8567719/
https://www.ncbi.nlm.nih.gov/pubmed/34732225
http://dx.doi.org/10.1186/s13023-021-02081-z

Ejemplares similares